HPV Symptoms: What Adults Should Know

Most people who contract Human Papillomavirus (HPV) never know they have it.

That silence is the virus’s primary clinical feature. Unlike infections that cause immediate fever, pain, or pronounced discharge, HPV lives quietly inside epithelial cells. For roughly nine out of ten people, the immune system suppresses or clears the infection within two years without producing a single detectable sign.

However, when HPV does make itself known, the presentation depends heavily on which specific viral strain is involved.

Understanding what HPV symptoms look like—and what they do not look like—is critical for separating harmless benign growths from the silent cellular changes that require medical intervention.

Low-Risk vs. High-Risk HPV: The Critical Clinical Difference

HPV is not a single disease. It is a family of more than 200 related viruses, around 40 of which spread through direct skin-to-skin sexual contact. Clinically, medical providers divide these genital strains into two distinct categories:

1. Low-Risk HPV (The Wart-Forming Strains)

Low-risk types do not cause cancer. Instead, they cause benign epithelial growths.

Strains 6 and 11 account for roughly 90% of all genital warts (condylomata acuminata). While cosmetically distressing and sometimes physically uncomfortable, these strains do not integrate into cellular DNA in ways that trigger malignancy.

2. High-Risk HPV (The Pre-Cancerous Strains)

High-risk strains—most notably HPV 16 and 18, along with about a dozen others—are oncogenic.

These strains produce no visible warts, no initial pain, and no everyday symptoms. Instead, they can slowly alter the DNA of cervical, anal, penile, vulvar, vaginal, or oropharyngeal (throat) cells over 10 to 20 years, potentially progressing to pre-cancer or invasive cancer if left undetected.

Visible Signs: What Genital Warts Actually Look and Feel Like

When low-risk HPV causes symptoms, genital warts generally appear weeks, months, or sometimes years after exposure. Their presentation varies substantially from person to person:

• Appearance: They can look like small, raised bumps that match surrounding flesh tones, or they may appear slightly darker or lighter. In some cases, clusters group together to form a rough, cauliflower-like surface. In other instances, they remain entirely flat and smooth, making them difficult to spot with the naked eye.
• Locations: In women, they frequently appear on the vulva, cervix, perineum, or around and inside the anus. In men, they commonly develop on the shaft or glans of the penis, scrotum, groin, or anal area.
• Physical Sensation: Genital warts are rarely excruciatingly painful. More often, people report mild localized itching, tenderness, burning, or occasional bleeding if the lesions become irritated by tight clothing, shaving, or sexual activity.

It is worth noting that small bumps in the genital region are frequently mistaken for HPV. Normal anatomical variations—such as pearly penile papules or vestibular papillomatosis—as well as non-viral issues like folliculitis, ingrown hairs, and sebaceous cysts, are routinely confused with genital warts. A physical exam by a healthcare provider can quickly distinguish between them.

The Danger of Invisibility: Why High-Risk HPV Causes No Early Symptoms

The most dangerous misconception about HPV is the belief that feeling healthy means you are clear of the virus.

High-risk HPV infections on the cervix, anus, or oropharynx do not cause pain, burning during urination, abnormal itching, or noticeable systemic signs during their early stages. The virus quietly disrupts regular cell turnover, producing microscopic abnormalities known as dysplasia.

By the time physical symptoms from high-risk HPV finally emerge, the infection has often progressed to advanced pre-cancer or invasive cancer:

Potential Cancer Site	Associated HPV Strains	Possible Later-Stage Symptoms to Watch For
Cervix	16, 18, 31, 33, 45, 52, 58	Abnormal vaginal bleeding between periods, bleeding after intercourse, unusual watery or foul-smelling discharge, or pelvic pain.
Oropharynx (Back of Throat / Tonsils)	Primarily 16	Persistent sore throat, unilateral ear pain, difficulty swallowing, a chronic raspy voice, or an unexplained painless lump in the neck.
Anus	Primarily 16	Anal bleeding, persistent itching, pain or pressure around the anus, or swollen lymph nodes in the groin.
Penis / Vulva	Primarily 16, 18	Thickening skin, persistent color changes, non-healing sores, chronic itching, or a palpable lump on the external tissue.

Screening and Diagnosis in Adults: What Modern Guidelines Say

Because high-risk HPV does not announce itself, routine clinical screening remains the primary defense against cervical cancer.

In the United States, primary cervical screening recommendations from the U.S. Preventive Services Task Force (USPSTF) focus on women aged 21 to 65:

• Ages 21–29: A Pap smear alone every 3 years. Routine HPV co-testing is generally not recommended in this group because transient, harmless HPV infections are extremely common and usually clear spontaneously without intervention.
• Ages 30–65: Three valid screening options exist: high-risk HPV testing alone every 5 years, HPV/Pap co-testing every 5 years, or a Pap smear alone every 3 years.

What About Men and Non-Cervical Sites?

Currently, there is no FDA-cleared routine HPV screening test for men, nor is there a validated swab to detect HPV in the throat, mouth, or penis. For these reasons, routine universal screening for non-cervical HPV is not performed in the general population.

High-resolution anoscopy and anal cytology are sometimes utilized for high-risk individuals (such as immunocompromised adults or those living with HIV), but standard asymptomatic screening does not exist for the broader public. Diagnosis in men typically occurs only when visible warts appear or when an unrelated medical exam identifies unusual tissue.

Prevention and Realistic Next Steps

A positive HPV test or a diagnosis of genital warts can bring unexpected emotional distress, largely due to social stigma. However, HPV is extraordinarily common; the CDC notes that nearly all sexually active adults contract at least one strain at some point in their lives.

To protect yourself and manage exposure risk:

1. Discuss the HPV Vaccine (Gardasil 9): While the vaccine is routinely administered around age 11–12, current CDC and ACIP guidelines approve catch-up vaccination for all adults through age 26. For adults aged 27 through 45 who were not vaccinated earlier, clinical shared decision-making with a physician is recommended. While the vaccine does not treat an existing strain, it provides durable protection against other high-risk and wart-causing strains you have not yet encountered.
2. Adhere to Regular Cervical Screenings: Attending scheduled Pap and HPV screenings remains the single most reliable way to catch cervical cellular changes before they advance.
3. Use Barrier Protection: Condoms and dental dams significantly lower transmission rates, though they do not offer 100% protection because the virus spreads through direct skin contact on areas not covered by the barrier.
4. Seek Evaluation for Unexplained Lesions: If you notice new bumps, rough spots, unexplained bleeding, or persistent throat discomfort, consult a primary care provider, gynecologist, or urologist for an accurate diagnosis rather than attempting over-the-counter wart removals designed for hands and feet.

Sources

• Centers for Disease Control and Prevention (CDC):Human Papillomavirus (HPV) Infection and Associated Cancers. Current clinical surveillance and vaccination recommendations.
• U.S. Preventive Services Task Force (USPSTF):Cervical Cancer: Screening. Clinical recommendations on cervical cytology and high-risk HPV testing intervals.
• National Cancer Institute (NCI):HPV and Cancer. Evidence on oncogenic strains (HPV 16 and 18) and related cellular dysplasia.
• American College of Obstetricians and Gynecologists (ACOG):Cervical Cancer Screening and Prevention Practice Advisory.